The Shroom Boom and other Therapeutic Psychedelics for the Win
Setup
Mental-health and substance-use disorders — arguably more prevalent than ever during the pandemic — are a leading cause of disability globally. So it’s no wonder the clinical use of psychedelic drugs to help treat psychiatric disorders, including anxiety, depression, and PTSD, is fueling a research renaissance. Even Wall Street is taking notice: Three psychedelic drug developers have gone public in the last several months. Two leaders at the forefront of the field shed light on the science of psilocybin, MDMA, and ketamine and their use in psychedelic-assisted psychotherapy.
Explore More
Health
Our changing climate represents one of the greatest challenges to health for the 21st century. Though all of humankind is at risk, communities with weak health and public heal...
Soon, we may be able to visualize any biological process in the human body, at any scale, in real time. Here’s what it will take to get there. Presented by Chan Zuckerberg Ini...
Katie Keith is director of the Health Policy and the Law Initiative at Georgetown University Law Center, where she is adjunct professor of law. Keith’s analysis focuses on way...
Watch select daily livestreams and join the virtual #AspenIdeasHealth conversation from June 22-25!
Neurologist Anjan Chatterjee explains why humans evolved to enjoy beauty, how sociocultural contexts shape our aesthetic preferences, and the "beauty is good" stereotype.
Race, ethnicity, age, sex, environment, and other social determinants of health can all impact how different people respond to the same medicine or vaccine. This is why divers...
"My organization in Tulsa is making pregnancy tests, emergency contraception, and condoms available, but these solutions need to be scaled and distributed more broadly." Laura...
"As long as my existence as a Black physician is noteworthy, communities of underrepresented minorities’ health will suffer." Jabraan Pasha, a 2022 Aspen Healthy Communities F...
Meet Lea Masamo, a 2022 Aspen Ideas: Health Fellow who's building a movement of people living with sickle cell disease to advocate for programs and policies needed to improve...
Meet Kistein Monkhouse, a 2022 Aspen Ideas: Health Fellow who's bridging gaps in patient/provider communication with a storytelling app that empowers people to own the narrati...
Meet Neale Batra, a 2022 Aspen Ideas: Health Fellow who's on a mission make the field of epidemiology more efficient, collaborative, and equitable through open-source software...
Meet Lucy He, a 2022 Aspen Ideas: Health Fellow who's using technology and policy change to address critical delays in patient care caused by the "prior authorization" process...
Can the data collected through smartphones, wearable sensors, and passive monitoring devices be turned into actionable knowledge about the environmental impacts on our health?...
Hospitals and health systems have a critical role to play in turning health equity talk into action. Learn how the field is using strategic investments to drive innovative sol...
From blockchain to back to school and virus-hunting to bridging divides, speakers at the 2021 Aspen Ideas Festival addressed issues in a new kind of world—one touched, and cha...
Did you know that only 7% of the investments made within the $715 billion global impact investing market go toward health? Learn how Johnson & Johnson Impact Ventures is leadi...
Two pioneering doctors are saving lives and making surgeries safer with new, innovative approaches. Presented by Mount Sinai Health System
